Northwestern Mutual Wealth Management
TVRD

Northwestern Mutual Wealth Management’s Tvardi Therapeutics TVRD Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-56
Closed -$622 – 3934
2024
Q3 		$622 Buy
+56
New +$656 ﹤0.01% 3315
2020
Q2 		– Sell
-10
Closed -$5K – 2726
2020
Q1 		$5K Buy
+10
New +$5.43K ﹤0.01% 2091

Other funds holding TVRD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Northwestern Mutual Wealth Management's TVRD Position: Q4 2024 in Review

Northwestern Mutual Wealth Management sold out of Tvardi Therapeutics (TVRD) in Q4 2024, closing a stake of 56 shares — an estimated $622 sold.

Northwestern Mutual Wealth Management first reported a position in TVRD in Q1 2020 and held it in 2 quarters. The position peaked at $5K in Q1 2020. 43 funds tracked by Wall St. Rank hold TVRD as of Q4 2024.

  • Northwestern Mutual Wealth Management reported no remaining Tvardi Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 56 Tvardi Therapeutics shares in Q4 2024, an estimated $622.
  • Northwestern Mutual Wealth Management first reported a position in Tvardi Therapeutics in Q1 2020 and held it in 2 quarters.
  • Northwestern Mutual Wealth Management's Tvardi Therapeutics position peaked at $5K in Q1 2020.
  • 43 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q4 2024.

Based on Northwestern Mutual Wealth Management's 13F filing for Q4 2024, filed 11 Feb 2025.